0

CAFERGOT از شرکت NOVARTIS

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CAFERGOT از شرکت NOVARTIS

New Drug Application (NDA): 009000

Company: NOVARTIS


Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CAFERGOT CAFFEINE; ERGOTAMINE TARTRATE 100MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** SUPPOSITORY;RECTAL Discontinued

None

Yes No


Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/24/1953 ORIG-1 Approval

Type 4 – New Combination

PRIORITY

Label is not available on this site.
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
11/07/2001 SUPPL-28 Manufacturing (CMC)

Label is not available on this site.
04/02/2001 SUPPL-27 Manufacturing (CMC)

Label is not available on this site.
03/29/2001 SUPPL-26 Manufacturing (CMC)-Control

Label is not available on this site.
05/16/2000 SUPPL-24 Manufacturing (CMC)

Label is not available on this site.
06/04/2002 SUPPL-23 Labeling

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/9000s22s23lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/9000s022ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/09000_S022&S023_Cafergot_APPROVAL PACKAGE.pdf
06/04/2002 SUPPL-22 Labeling

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/9000s22s23lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/9000s022ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/09000_S022&S023_Cafergot_APPROVAL PACKAGE.pdf
10/31/2000 SUPPL-21 Labeling

Label is not available on this site.
10/31/2000 SUPPL-20 Labeling

Label is not available on this site.
07/14/1993 SUPPL-19 Manufacturing (CMC)-Control

Label is not available on this site.
10/31/2000 SUPPL-17 Labeling

Label is not available on this site.
04/15/1993 SUPPL-16 Manufacturing (CMC)-Control

Label is not available on this site.
10/31/2000 SUPPL-15 Labeling

Label is not available on this site.
03/04/1994 SUPPL-14 Manufacturing (CMC)

Label is not available on this site.
10/31/2000 SUPPL-13 Labeling

Label is not available on this site.
11/17/1988 SUPPL-12 Manufacturing (CMC)

Label is not available on this site.
02/10/1989 SUPPL-11 Manufacturing (CMC)-Control

Label is not available on this site.
11/15/1988 SUPPL-10 Manufacturing (CMC)-Control

Label is not available on this site.
07/25/1986 SUPPL-9 Manufacturing (CMC)-Control

Label is not available on this site.
01/16/1985 SUPPL-7 Manufacturing (CMC)-Control

Label is not available on this site.
07/15/1981 SUPPL-6 Manufacturing (CMC)-Packaging

Label is not available on this site.
01/29/1981 SUPPL-5 Manufacturing (CMC)-Packaging

Label is not available on this site.
11/06/1979 SUPPL-4 Manufacturing (CMC)-Packaging

Label is not available on this site.
07/19/1979 SUPPL-3 Manufacturing (CMC)-Packaging

Label is not available on this site.


Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert		 Note Url
06/04/2002 SUPPL-23

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/9000s22s23lbl.pdf
06/04/2002 SUPPL-22

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/9000s22s23lbl.pdf
حتما بخوانید : CABLIVI از شرکت ABLYNX NV
برچسب‌ها:

صفحات پیشنهادی

کلینیک ترک اعتیاد تهران

دکتر مهدی قاضی

متخصص اورولوژی مشهد

دکتر پروستات در مشهد

دکتر زگیل تناسلی در مشهد

وازکتومی در مشهد

مشاهده بیشتر

نظرات کاربران

مشاهده بیشتر

بیماری های روان پزشکی
بیماری های قلب و عروق
زیبایی و سلامت
مطالب آموزشی